Monoclonal antibodies are typically administered via intravenous (IV) infusion, although some can be given subcutaneously. The infusion process can vary in length, often lasting from 30 minutes to a few hours depending on the specific mAb and its formulation. Nursing staff must monitor patients for any adverse reactions during and after the administration.